X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sun Pharma with FDC LTD. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs FDC LTD. - Comparison Results

SUN PHARMA    Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUN PHARMA FDC LTD. SUN PHARMA/
FDC LTD.
 
P/E (TTM) x 44.4 23.9 185.5% View Chart
P/BV x 3.6 4.8 75.2% View Chart
Dividend Yield % 0.6 1.0 64.6%  

Financials

 SUN PHARMA   FDC LTD.
EQUITY SHARE DATA
    SUN PHARMA
Mar-17
FDC LTD.
Mar-14
SUN PHARMA/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs842144 586.8%   
Low Rs57279 724.6%   
Sales per share (Unadj.) Rs131.647.6 276.7%  
Earnings per share (Unadj.) Rs32.77.6 429.8%  
Cash flow per share (Unadj.) Rs38.09.0 421.5%  
Dividends per share (Unadj.) Rs3.502.25 155.6%  
Dividend yield (eoy) %0.52.0 24.5%  
Book value per share (Unadj.) Rs152.747.5 321.3%  
Shares outstanding (eoy) m2,399.26177.83 1,349.2%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x5.42.3 229.7%   
Avg P/E ratio x21.614.6 147.9%  
P/CF ratio (eoy) x18.612.3 150.8%  
Price / Book Value ratio x4.62.3 197.9%  
Dividend payout %10.729.6 36.2%   
Avg Mkt Cap Rs m1,696,87719,784 8,577.2%   
No. of employees `00017.5NA-   
Total wages/salary Rs m49,0231,221 4,016.6%   
Avg. sales/employee Rs Th18,028.3NM-  
Avg. wages/employee Rs Th2,798.8NM-  
Avg. net profit/employee Rs Th4,479.5NM-  
INCOME DATA
Net Sales Rs m315,7848,459 3,733.3%  
Other income Rs m6,232394 1,583.4%   
Total revenues Rs m322,0168,852 3,637.8%   
Gross profit Rs m100,8932,070 4,873.7%  
Depreciation Rs m12,648249 5,077.3%   
Interest Rs m3,99831 12,892.6%   
Profit before tax Rs m90,4792,184 4,143.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m99-225 -44.2%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m12,116606 2,000.8%   
Profit after tax Rs m78,4621,353 5,798.5%  
Gross profit margin %31.924.5 130.5%  
Effective tax rate %13.427.7 48.3%   
Net profit margin %24.816.0 155.3%  
BALANCE SHEET DATA
Current assets Rs m329,5374,355 7,566.3%   
Current liabilities Rs m178,8701,792 9,982.2%   
Net working cap to sales %47.730.3 157.4%  
Current ratio x1.82.4 75.8%  
Inventory Days Days7944 177.7%  
Debtors Days Days8325 337.5%  
Net fixed assets Rs m204,7663,025 6,769.1%   
Share capital Rs m2,399179 1,343.4%   
"Free" reserves Rs m363,9978,243 4,416.1%   
Net worth Rs m366,3978,453 4,334.5%   
Long term debt Rs m14,36111 134,213.1%   
Total assets Rs m614,10210,557 5,817.0%  
Interest coverage x23.671.4 33.1%   
Debt to equity ratio x00 3,096.4%  
Sales to assets ratio x0.50.8 64.2%   
Return on assets %13.413.1 102.4%  
Return on equity %21.416.0 133.8%  
Return on capital %24.823.5 105.7%  
Exports to sales %013.3 0.0%   
Imports to sales %03.3 0.0%   
Exports (fob) Rs mNA1,126 0.0%   
Imports (cif) Rs mNA283 0.0%   
Fx inflow Rs m44,1181,146 3,849.4%   
Fx outflow Rs m24,484355 6,891.1%   
Net fx Rs m19,634791 2,482.8%   
CASH FLOW
From Operations Rs m70,8221,485 4,769.5%  
From Investments Rs m-42,216-620 6,814.5%  
From Financial Activity Rs m-22,854-753 3,037.1%  
Net Cashflow Rs m6,107113 5,413.7%  

Share Holding

Indian Promoters % 63.7 68.9 92.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 5.1 4.7 109.1%  
FIIs % 23.0 7.5 306.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 8.3 19.0 43.7%  
Shareholders   133,026 23,730 560.6%  
Pledged promoter(s) holding % 0.5 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUN PHARMA With:   CIPLA  PIRAMAL ENTERPRISES  NATCO PHARMA  SHASUN PHARMA  PFIZER  

Compare SUN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Volatile Day Flat; Pharma Stocks Top Losers(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day flat.

Related Views on News

SUN PHARMA Announces Quarterly Results (4QFY18); Net Profit Up 12.0%

May 28, 2018 | Updated on May 28, 2018

For the quarter ended March 2018, SUN PHARMA has posted a net profit of Rs 16 bn (up 12.0% YoY). Sales on the other hand came in at Rs 70 bn (down 2.2% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

How to Avoid a 90% Loss Suffered by This Super Investor(The 5 Minute Wrapup)

Jul 12, 2018

Blindly following super investors is a dangerous game to play. Here's how you can avoid such mistakes.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

New Fund Offer - ICICI Prudential Pharma Healthcare and Diagnostics Fund - Should You Invest?(Outside View)

Jul 6, 2018

ICICI AMC launches an open -ended equity fund following Pharma, Healthcare, Diagnostic and allied theme.

When Disappointment Panda is Around. Buy Quality Stock like This!(Chart Of The Day)

Jul 6, 2018

Buy Companies that can fight all kinds of Pandas and Bears in the long run.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Jul 19, 2018 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA - IPCA LABS COMPARISON

COMPARE SUN PHARMA WITH

MARKET STATS